소아 비만에서 Leptin, Adiponectin 및 Leptin/Adiponectin Ratio와 대사 장애의 연관성에 관한 연구

조성종,김은영,문경래,Cho, Sung Jong,Kim, Eun Young,Moon, Kyung Rye 대한소아소화기영양학회 2006 Pediatric gastroenterology, hepatology & nutrition Vol.9 No.1

목 적: 연구자는 adipocytokine의 일종인 leptin, adiponectin과 leptin/adiponectin 비를 이용하여 비만아에서 신체 계측치와 인슐린, 지질 농도와의 상관관계를 알아보고자 한다. 방 법: 2005년 1월부터 2005년 6월까지 조선대학교병원 소아과에 방문한 BMI 95백분위수 이상인 7~15세 사이의 비만군 25명(남: 20명, 여: 5명)과 정상 체중 아동인 대조군 25명(남: 20명, 여: 5명)을 대상으로 하였다. 신체 계측(신장, 체중, 팔둘레, 피부주름두께, 체지방률)을 시행하고 공복상태에서 채혈하여 adiponectin, leptin과 혈당, 인슐린, 지질 농도를 측정하였다. 통계는 Student t-test와 Pearson's correlation coefficient 분석법을 이용하였다. 결 과: 비만군에서 대조군에 비해 체질량 지수, 체지방률, 팔둘레, 삼두박근 피부주름두께 및 견갑골하 피부주름두께가 대조군에 비해 유의하게 높았고, 인슐린 농도($17.9{\pm}15.6{\mu}U/mL$ vs $6.5{\pm}2.7{\mu}U/mL$, p<0.05)는 유의하게 높았으며 고밀도 지질 단백 콜레스테롤($50.0{\pm}12.4mg/dL$ vs $68.9{\pm}15.9mg/dL$, p<0.005)은 유의하게 낮았다. Leptin은 비만군에서 $10.6{\pm}5.1ng/mL$로 대조군에 비해 유의하게 높았고(p<0.001), adiponectin은 비만군에서 $2.85{\pm}0.7{\mu}g/mL$로 유의하게 낮았다.(p<0.05). 비만군에서 leptin은 체질량지수, 체지방률과 유의한 양의 상관관계를 보였고 adiponectin은 체질량지수, 체지방률과 유의한 음의 상관관계가 있었다. 대조군에서 leptin은 유의한 상관관계를 보인 인자가 없었으나, adiponectin은 인슐린과 유의한 양의 상관관계가 있었다. Leptin/adiponectin 비는 비만군에서 대조군에 비해 유의하게 높았고($4.03{\pm}2.8$ vs $1.53{\pm}0.74$, p<0.01), 비만군에서는 체지방률, leptin과 유의한 양의 상관관계가 있었으나 대조군에서는 체질량지수 및 체지방률과 유의한 양의 상관관계가 있었다. 결 론: 소아비만에서 leptin과 adiponectin은 비만지표들과 유의한 연관성이 있었음에도 불구하고, 대사장애를 나타내는 인자들과는 연관성이 없었다. Leptin/adiponectin 비는 비만군에서 대조군에 비해 유의하게 높았고, 비만군뿐만 아니라 대조군에서도 비만지표들과 유의한 상관관계가 있었다. Purpose: To investigate the correlation of the serum leptin, adiponectin, and leptin/adiponectin ratio with metabolic disorders in the childhood obesity. Methods: Fifty children (25 obese and 25 non-obese) were recruited in the pediatric outpatient clinic of Chosun University Hospital from January 1st to June 30th 2005. Adiponectin, leptin, anthropometric parameters, glucose, LDL-cholesterol, HDL-cholesterol, total cholesterol, triglyceride, and insulin levels were measured. The correlations of leptin and adiponectin levels with anthropometric parameters, glucose, insulin and lipids were analyzed by Pearson's correlation coefficients. Results: Insulin and leptin levels of the obese group were significantly higher than those of the non-obese group (p<0.05, p<0.001 respectively). HDL-cholesterol and adiponectin levels of the obese group were significantly lower than those of the non-obese group (p<0.005, p<0.05 respectively). In the obese group, leptin level was positively correlated with BMI and the percentage of body fat, but negatively correlated with adiponectin level. Moreover, adiponectin level of the obese group was negatively correlated with BMI and the percentage of body fat, but positively correlated with leptin level. In the non-obese group, only insulin level was positively correlated with adiponectin. In the obese group, leptin/adiponectin ratio was positively correlated with the percentage of body fat and leptin level. Also, leptin/adiponectin ratio was positively correlated with BMI and the percentage of body fat in the non-obese group. Conclusion: Leptin, adiponectin, and leptin/adiponectin ratio did not appear to have a major role linking various metabolic disorders in the childhood obesity, even though they were strongly associated with obesity indices. Also, leptin/adiponectin ratio was associated with obesity indices even in non-obese children.

Decreased plasma adiponectin among male firefighters with symptoms of post-traumatic stress disorder

Na, Kyoung-Sa,Kim, Eun-Kyoung,Park, Jong-Tae Elsevier 2017 Journal of affective disorders Vol.221 No.-

<P><B>Abstract</B></P> <P><B>Background</B></P> <P>Recent studies have reported that adiponectin-mediated neuromolecular pathways are involved in fear extinction, implying that adiponectin may be an important biological marker for posttraumatic stress disorder (PTSD). However, no study has investigated the association between adiponectin and patients with PTSD.</P> <P><B>Methods</B></P> <P>We examined plasma adiponectin levels, high-sensitivity C-reactive protein (hs-CRP), and psychopathological factors using the Korean version of the Impact Event Scale-Revised (IES-R-K) and the Center for Epidemiologic Studies Depression Scale in 507 male firefighters. The PTSD symptom group was defined as those with a score of 25 or higher on the IES-R-K. Multiple logistic regression analysis was conducted to examine the covariates for the PTSD symptom group.</P> <P><B>Results</B></P> <P>Out of 507 male firefighters, 139 (27.4%) had a score of 25 or more on the IES-R-K. The PTSD symptom group had lower plasma adiponectin levels than the controls. There was an inverse correlation between plasma adiponectin levels and PTSD severity. There was no correlation between adiponectin levels and depression. The adiponectin level was associated with the presence of PTSD symptom (odds ratio = 0.955, 95% CI = 0.920–0.991).</P> <P><B>Limitations</B></P> <P>A cross-sectional design and using self-rated instruments.</P> <P><B>Conclusions</B></P> <P>To the best of our knowledge, the results showed that decreased adiponectin-mediated activity is associated with PTSD. Future studies are necessary to identify the causative role of adiponectin for PTSD as well as any possible covariates.</P> <P><B>Highlights</B></P> <P> <UL> <LI> The plasma adiponectin level was inversely correlated with PTSD symptoms. </LI> <LI> The plasma adiponectin level was associated with a decreased odds ratio for PTSD. </LI> <LI> The plasma adiponectin level was not associated with depression. </LI> </UL> </P>

한국 청소년에서 혈청 Adiponectin 농도와 비만도와의 상관관계

김현아,이형숙,김철식,안철우,정윤석,이관우,허갑범,김대중 대한내분비학회 2003 Endocrinology and metabolism Vol.18 No.5

연구배경: Adiponectin은 지방세포에서 특이적으로 발현되고 분비되는 adipocytokine이다. 아직 adiponectin 과 소아 비만과의 관련성을 연구한 보고는 많지 않다. 본 연구에서는 한국 청소년을 대상으로 혈청 adiponectin농도와 비만도 및 심혈관계 질환의 위험인자들과의 상관관계를 보고자 하였다. 방법: 2003년 4월 서울특별시 서대문구 소재의 한 중학교에서 12∼15세의 무작위 선발된 164명을 연구 대상으로 하여 신장, 체중, 허리둘레, 체지방을 측정하고 체질량지수를 계산하였다. 또한 공복채혈을 통하여 콜레스테롤, HDL-콜레스테롤, 중성지방, 혈당 및 인슐린 농도를 측정하고 혈청 adiponectin 농도는 ELISA 방법을 이용하여 측정하였다. 결과: 혈청 adiponectin 농도에 따라 삼등분하여 저 adiponectin군, 중간 adiponectin군, 고 adiponectin군으로 나누고 각 군간에 신체계측치 및 임상적 특성을 비교 분석하였다. 저 adiponectin군에서 다른 군에 비해 체질량지수와 허리둘레가 의미있게 크게 나타났다. 또한 저 adiponectin군에서 공복혈당 및 공복혈청 인슐린 농도가 높게 나타났으며, HOMA-IR 값도 높게 나타났다. 저 adiponectin군에서 총콜레스테롤과 중성지방치는 높게, 그리고 HDL 콜레스테롤치는 낮게 나타났다. 다변량회귀분석을 시행한 결과 혈청 adiponectin농도와 가장 상관관계가 높은 변수는 허리둘레와 성별로 나타났다. 결론: 소아에서도 성인과 마찬가지로 혈청 adiponectin농도와 복부비만 및 심혈관계 질환의 위험인자들과의 강한 음의 상관관계를 보임을 알 수 있었다. 향후 사춘기 성호르몬의 변화가 adiponectin에 미치는 영향 및 소아비만의 치료에 따른 adiponectin의 변화 등에 대한 연구가 필요하리라 사료된다. Background: Adiponectin is an adipocytokine that is highly specific to adipose tissue. In contrast to other adipocytokine, the adiponectin levels are decreased in obesity and/or type 2 diabetes. There are few studies regarding the correlation between the adiponectin concentration and obesity in children. Thus, whether the serum adiponectin concentrations are associated with adiposity in children was investigated. Methods: One hundred and sixty four subjects were selected from the participants in an ongoing study on the relationship between birth weight and insulin resistance in children. The current weights, heights, body fat percentages, waist circumferences, blood pressures, lipid profiles and insulin resistance, by the HOMA method, were measured in all the subjects. The serum adiponectin concentrations were determined by a validated sandwich ELISA, using a human adiponectin-specific antibody. Results: The serum adiponectin concentration was negatively correlated with the body mass index, waist circumference, systolic blood pressure, insulin resistance by HOMA and serum triglycerides, and positively correlated with the serum HDL cholesterol level. The serum adiponectin concentrations in the boys were significantly lower than in the girls. In a multiple regression analysis, the serum adiponectin concentration was strongly associated with waist circumference and gender. Conclusion: It is concluded that there was an inverse relationship between the serum adiponectin concentration and abdominal adiposity in children. However, further studies on independent gender differences on adiponectin are needed (J Kor Soc Endocrinol 18:473∼480, 2003).

Adiponectin Regulation of Glucose Uptake and Growth in Mammary Epithelial Cells

여인서,박병성,고용균,양부근 강원대학교 동물자원공동연구소 2015 동물자원연구 Vol.26 No.2

The objective of the research was to identify the presence of adiponectin receptors and to study adiponectin action on glucose uptake and growth in mouse mammary epithelial cells. These cells expressed adiponectin receptors, AdipoR1 and AdipoR2. Insulin (10 ng/ml) or insulin like growth factor-I (IGF-I, 10 ng/ml) alone did not alter the degree of AdipoR1 and AdipoR2 genes expression from 0 to 4 h incubation. Prolactin (10 ng/ml) or epidermal growth factor (EGF, 10 ng/ml) alone also did not induce the two genes’ mRNA in the incubation time. Adiponectin (1 μg/ml) alone or pre-incubation of insulin alone (100 ng/ml) for 2 h prior to adiponectin stimulation did not increase 2-deoxy-D-glucose,[1,2-3H] uptake but adiponectin+pre-incubation of insulin significantly increased glucose uptake compare to control (p<0.05). In a similar way, insulin alone or pre-incubation of adiponectin alone (2 h) did not increase glucose uptake but insulin+pre-incubation of adiponectin increased glucose uptake compare to control (p<0.05). Insulin sensitization for 2 h prior to adiponectin stimulation tended to increase glucose uptake response by the following adiponectin stimulation showing small interaction effect between insulin and adiponectin (p<0.1). However, adiponectin sensitization for 2 hours prior to insulin stimulation did not shown interaction effect between adiponectin and insulin (p>0.1). The glucose uptake by both of hormones seems to be not interactive but additive (p<0.05). Adiponectin in the presence of 2% FBS decreased DNA synthesis of mammary epithelia (p<0.05). AICAR (100 or 200 μM), AMPK activator, decreased mammary epithelial cell growth in the presence of 2% FBS. These results indicate that adiponectin pathway has inhibitory effect on mammary epithelial cell growth.

Adiponectin에 의한 유선상피세포의 글루코스 흡수 및 성장조절작용

여인서,박병성,고용균,양부근 강원대학교 동물생명과학연구소(구 강원대학교 동물자원공동연구소) 2015 동물자원연구 Vol.26 No.2

The objective of the research was to identify the presence of adiponectin receptors and to study adiponectin action on glucose uptake and growth in mouse mammary epithelial cells. These cells expressed adiponectin receptors, AdipoR1 and AdipoR2. Insulin (10 ng/ml) or insulin like growth factor-I (IGF-I, 10 ng/ml) alone did not alter the degree of AdipoR1 and AdipoR2 genes expression from 0 to 4 h incubation. Prolactin (10 ng/ml) or epidermal growth factor (EGF, 10 ng/ml) alone also did not induce the two genes’ mRNA in the incubation time. Adiponectin (1 μg/ml) alone or pre-incubation of insulin alone (100 ng/ml) for 2 h prior to adiponectin stimulation did not increase 2-deoxy-D-glucose,[1,2-3H] uptake but adiponectin+pre-incubation of insulin significantly increased glucose uptake compare to control (p<0.05). In a similar way, insulin alone or pre-incubation of adiponectin alone (2 h) did not increase glucose uptake but insulin+pre-incubation of adiponectin increased glucose uptake compare to control (p<0.05). Insulin sensitization for 2 h prior to adiponectin stimulation tended to increase glucose uptake response by the following adiponectin stimulation showing small interaction effect between insulin and adiponectin (p<0.1). However, adiponectin sensitization for 2 hours prior to insulin stimulation did not shown interaction effect between adiponectin and insulin (p>0.1). The glucose uptake by both of hormones seems to be not interactive but additive (p<0.05). Adiponectin in the presence of 2% FBS decreased DNA synthesis of mammary epithelia (p<0.05). AICAR (100 or 200 μM), AMPK activator, decreased mammary epithelial cell growth in the presence of 2% FBS. These results indicate that adiponectin pathway has inhibitory effect on mammary epithelial cell growth.

Adiponectin과 Leptin이 전립선암 세포의 증식에 미치는 영향

이소연,박세준,장인호,명순철,김태형 대한비뇨의학회 2009 Investigative and Clinical Urology Vol.50 No.5

Purpose: With the westernization of dietary life, domestic prostate cancer prevalence has remarkably increased recently. Therefore, to examine the effects of obesity on prostate cancer, we analyzed the effects of leptin and adiponectin, which are the cytokines secreted from adipocytes, on prostate cancer in vitro and confirmed the results by in vivo experiment. Materials and Methods: In vitro, the human androgen-independent prostate cancer cell line DU-145 was exposed to various concentrations of adiponectin and leptin, and their effects were measured with the 3-(4,5- dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. In vivo, the effects of tumor growth were observed in xenografted nude mice with prostate cancer. Results: Adiponectin significantly repressed DU-145 cell growth in a dose- dependent manner. Leptin promoted DU-145 cell growth in dose-dependent manner, but it was not significant statistically. In vivo, adiponectin- treated mice demonstrated a reduced tumor volume, although it was not significant statistically. By contrast, leptin-treated mice showed a significantly increased tumor volume (p<0.01). Conclusions: The in vitro and in vivo finding suggested that adiponectin suppresses the proliferation of prostate cancer cells and that leptin plays an important role in the proliferation of prostate cancer cells. We suggest that adiponectin and leptin have a relation to the progression of prostate cancer in the obese population. Purpose: With the westernization of dietary life, domestic prostate cancer prevalence has remarkably increased recently. Therefore, to examine the effects of obesity on prostate cancer, we analyzed the effects of leptin and adiponectin, which are the cytokines secreted from adipocytes, on prostate cancer in vitro and confirmed the results by in vivo experiment. Materials and Methods: In vitro, the human androgen-independent prostate cancer cell line DU-145 was exposed to various concentrations of adiponectin and leptin, and their effects were measured with the 3-(4,5- dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. In vivo, the effects of tumor growth were observed in xenografted nude mice with prostate cancer. Results: Adiponectin significantly repressed DU-145 cell growth in a dose- dependent manner. Leptin promoted DU-145 cell growth in dose-dependent manner, but it was not significant statistically. In vivo, adiponectin- treated mice demonstrated a reduced tumor volume, although it was not significant statistically. By contrast, leptin-treated mice showed a significantly increased tumor volume (p<0.01). Conclusions: The in vitro and in vivo finding suggested that adiponectin suppresses the proliferation of prostate cancer cells and that leptin plays an important role in the proliferation of prostate cancer cells. We suggest that adiponectin and leptin have a relation to the progression of prostate cancer in the obese population.

Adiponectin과 체내 지방분포, 인슐린 저항성, 콜레스테롤의 상관관계 : in Healthy Premenopausal Women

권기환,곽재진,박시훈 대한순환기학회 2003 Korean Circulation Journal Vol.33 No.11

Adiponectin의 임상적 의미

임수,장학철 대한당뇨병학회 2008 Diabetes and Metabolism Journal Vol.32 No.2

Adipose tissue is now considered as an active hormone-secreting organ, which secretes a number of biologically active adipokines such as free fatty acids, leptin, tumor necrosis factor alpha (TNFα), interleukin-6, plasminogen activator inhibitor-1, adiponectin and retinol binding protein 4 (RBP4). Among these, adiponectin has attracted considerable attention as an adipokine that has important role in the development of type 2 diabetes, atherosclerosis and cardiovascular diseases. Adiponectin was discovered to be the most abundant adipose-specific transcript. Many epidemiological and clinical studies have demonstrated that serum levels of adiponectin are inversely associated with body weight, especially abdominal visceral fat accumulation. Studies among Japanese and Pima Indians have reported lower concentrations of adiponectin in patients with type 2 diabetes than in those with normal glucose tolerance. A low level of adiponectin was found to be a significant risk factor for the development of cardiovascular events in the Korean patients with type 2 diabetes. We recently published that exercise, having an insulin-sensitizing effect, could be a good therapy to prevent or delay diabetes and cardiovascular diseases in middle-aged women through the modification of adiponectin. These results suggest that the clinical implication of adiponectin. A number of studies have been conducted to clarify the biological role of adiponectin. Recent studies have showed that adiponectin has anti-inflammatory, anti-atherogenic, and glucose-lowering properties. Taken together, it is conceivable that adiponectin plays as a backbone of metabolic syndrome. Finally, pleiotropic functions of adiponectin may possibly serve to prevent and treat atherosclerosis, type 2 diabetes and cardiovascular diseases. Furthermore, enhancement of adiponectin secretion or action may be a good therapeutic target for preventing type 2 diabetes or cardiovascular diseases. (KOREAN DIABETES J 32:85-97, 2008)

Cord Blood Adiponectin and Insulin-like Growth Factor-I in Term Neonates of Gestational Diabetes Mellitus Mothers: Relationship to Fetal Growth

박은애,손진아,조수진,김영주,박혜숙 대한신생아학회 2011 Neonatal medicine Vol.18 No.1

Purpose: The purpose of this study was to evaluate the relationship between cord blood adiponectin and insulin-like growth factor (IGF)-I and their effect on fetal growth and insulin resistance in mothers with gestational diabetes mellitus (GDM). Methods: Cord blood adiponectin and IGF-I were compared between mothers with GDM (GDM group, N=53) and controls (non-GDM group, N=101). Neonates were classified into three groups of small for gestational age (SGA, N=26), appropriate for gestational age (AGA, N=97), and large for gestational age (LGA, N=31) by birth weight. The association between cord adiponectin and IGF-I levels was evaluated in relation to maternal and neonatal clinical data. Results: Cord adiponectin was lower in the GDM group than in the non-GDM group (P<0.001). There was no significant difference in cord adiponectin among the SGA, AGA, and LGA groups in the GDM group (P=0.228). The cord adiponectin of AGA in the GDM group was significantly lower than that in the non-GDM group (P<0.001). The most powerful predictor affecting cord adiponectin was the result of maternal 75 g OGTT. The cord IGF-I values between the GDM group and the non-GDM group were not different (P=0.834). Neonates with the heavier birth weight had the higher cord IGF-I levels. The most powerful predictor affecting cord IGF-I was birth weight and the next was maternal parity. Conclusion: Both cord blood adiponectin and IGF-I were associated with fetal growth, but IGF-I was a more general and direct factor affecting fetal body size, and adiponectin seemed to have more association with insulin sensitivity than growth. 목적: 임신성 당뇨는 임신의 흔한 합병증 중의 하나이며 임신성 당뇨 산모의 아기는 정상 산모의 아기에 비해서 체지방률이높다. Adiponectin은 인슐린 민감성 조직에서 당과 지방 대사를 조절하는 중요한 물질이며, insulin-like growth factor (IGF)-I은 출생 전후기에 성장을 조절하는 중요한 내분비 조절물질로 알려져 있다. 본 연구에서는 임신성 당뇨 산모의 아기에서 제대혈 adiponectin과 IGF-I 수치와 태아 성장과의 관계 및인슐린 저항성에 대해서 알아보고자 하였다. 방법: 임신성 당뇨 이외에 임신과 관련된 기타 합병증이 동반되지 않은 산모에서 태어난 아기(임신성 당뇨군, N=53)와 정상산모에서 태어난 아기(대조군, N=101)의 제대혈 adiponectin과IGF-Ⅰ 수치를 비교하였다. 신생아는 출생 체중에 따라 부당경량아(N=26), 적정체중아(N=97), 부당중량아(N=31)로 세분하였다. 제대혈 adiponectin, IGF-I 농도와 산모의 나이, 분만력, 임신 전 체질량지수, 공복 혈당 및 75 g 경구당부하검사, 임신 중산모 체중 증가, 태아-태반 무게비, 출생시 재태연령, 아기의 성별, 출생체중, 출생신장과의 관계를 비교하였다. 결과: 대조군보다 임신성 당뇨군에서 제대혈 adiponectin의평균이 의미 있게 낮았다(P<0.001). 임신성 당뇨군에서는 부당경량아군, 적정체중아군, 부당중량아군 사이의 제대혈adiponectin 수치에 유의한 차이를 보이지 않았으나(P=0.228),적정체중아군은 대조군의 적정체중아군에 비해 의미 있게 낮은 adiponectin 수치를 보였다(P<0.001). 제대혈 adiponectin 은 산모의 임신 전 체질량지수, 공복혈당, 75 g 경부당부하검사와 음의 상관관계를 가졌고, 출생시 재태연령, 출생체중, 제대혈IGF-I과 양의 상관관계를 가졌다. 다중선형회귀분석에서 75 g 경부당부하검사가 가장 강력한 예측인자로 나왔다. 임신성 당뇨군과 대조군 사이의 제대혈 IGF-I은 의미 있는 차이를 보이지않았다(P=0.834). 제대혈 IGF-I은 출생체중이 높은 군일수록의미 있게 높았다(P<0.001). 제대혈 IGF-I은 산모의 연령, 분만력, 출생체중, 출생신장, 제대혈 adiponectin과 유의한 양의 상관관계를 보였고, 이 중에서 출생체중과 분만력이 가장 강력한예측인자였다. 결론: 산모의 임신성 당뇨는 제대혈 adiponectin을 낮춘다. 제대혈 adiponectin과 IGF-I 모두 출생체중과 연관성을 보였지만 IGF-I이 태아의 성장에 좀 더 직접적인 영향을 미치며,adiponectin은 성장보다는 인슐린 저항성과 더 연관이 있는 것으로 생각된다. 그러므로 임신성 당뇨를 가진 산모에서 태어난아기는 적정체중아일지라도 생후 성장과 인슐린 저항성의 변화를 추적 관찰하는 것이 중요할 것이다.

Annexin A6 is highly abundant in monocytes of obese and type 2 diabetic individuals and is downregulated by adiponectin in vitro

Fabian Stögbauer,Johanna Weigert,Markus Neumeier,Josef Wanninger,Daniela Sporrer,Markus Weber,Andreas Schäffler,Carlos Enrich,Peta Wood,Thomas Grewal,Charalampos Aslanidis,Christa Buechler 생화학분자생물학회 2009 Experimental and molecular medicine Vol.41 No.7

Adiponectin stimulates cholesterol efflux in macrophages and low adiponectin may in part contribute to disturbed reverse cholesterol transport in type 2 diabetes. Monocytes express high levels of annexin A6 that could inhibit cholesterol efflux and it was investigated whether the atheroprotective effects of adiponectin are accompanied by changes in annexin A6 levels. Adiponectin reduces annexin A6 protein whereas mRNA levels are not affected. Adiponectin-mediated activation of peroxisome proliferator-activated receptor α (PPARα) and AMP-activated protein kinase (AMPK) does not account for reduced annexin A6 expression. Further, fatty acids and lipopolysaccharide that are elevated in obesity do not influence annexin A6 protein levels. Annexin A6 in monocytes from overweight probands or type 2 diabetic patients is significantly elevated compared to monocytes of normal- weight controls. Monocytic annexin A6 positively correlates with body mass index and negatively with systemic adiponectin of the blood donors. Therefore, the current study demonstrates that adiponectin reduces annexin A6 in monocytes and thereby may enhance cholesterol efflux. In agreement with these in vitro finding an increase of monocytic annexin A6 in type 2 diabetes monocytes was observed. Adiponectin stimulates cholesterol efflux in macrophages and low adiponectin may in part contribute to disturbed reverse cholesterol transport in type 2 diabetes. Monocytes express high levels of annexin A6 that could inhibit cholesterol efflux and it was investigated whether the atheroprotective effects of adiponectin are accompanied by changes in annexin A6 levels. Adiponectin reduces annexin A6 protein whereas mRNA levels are not affected. Adiponectin-mediated activation of peroxisome proliferator-activated receptor α (PPARα) and AMP-activated protein kinase (AMPK) does not account for reduced annexin A6 expression. Further, fatty acids and lipopolysaccharide that are elevated in obesity do not influence annexin A6 protein levels. Annexin A6 in monocytes from overweight probands or type 2 diabetic patients is significantly elevated compared to monocytes of normal- weight controls. Monocytic annexin A6 positively correlates with body mass index and negatively with systemic adiponectin of the blood donors. Therefore, the current study demonstrates that adiponectin reduces annexin A6 in monocytes and thereby may enhance cholesterol efflux. In agreement with these in vitro finding an increase of monocytic annexin A6 in type 2 diabetes monocytes was observed.